AFLIBERCEPT-YSZY | B761350 | SAMSUNG BIOEPIS CO LTD
Regulatory Exclusivities
| Type | Expiry | Status | Source |
|---|---|---|---|
| 12-Year BPCIA | May. 20, 2036 | Active | Computed |
Purple Book Patents
No listed patents in Purple Book.
Estimated Patent LOE
Based on latest discovered patent 12338274(formulation) · relevance 93/100
Estimate based on AI-discovered patents. No patents are officially listed in the Purple Book for this product.
Approved Biosimilars
Top 50 of 479 AI-discovered patents by relevance.
No patent or exclusivity listings for this strength.